104 related articles for article (PubMed ID: 32171677)
1. Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1.
Ramon-Duaso C; Rodríguez-Morató J; Selma-Soriano E; Fernández-Avilés C; Artero R; de la Torre R; Pozo ÓJ; Robledo P
Neuropharmacology; 2020 Jun; 170():108030. PubMed ID: 32171677
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.
Ramon-Duaso C; Gener T; Consegal M; Fernández-Avilés C; Gallego JJ; Castarlenas L; Swanson MS; de la Torre R; Maldonado R; Puig MV; Robledo P
Cereb Cortex; 2019 Jul; 29(7):2978-2997. PubMed ID: 30060068
[TBL] [Abstract][Full Text] [Related]
3. Altered Behavioral Responses Show GABA Sensitivity in Muscleblind-Like 2-Deficient Mice: Implications for CNS Symptoms in Myotonic Dystrophy.
Edokpolor KS; Banerjee A; McEachin ZT; Gu J; Kosti A; Arboleda JD; García PS; Wang ET; Bassell GJ
eNeuro; 2022; 9(5):. PubMed ID: 36150891
[TBL] [Abstract][Full Text] [Related]
4. Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.
Wang LH; Lin CY; Lin YM; Buée L; Sergeant N; Blum D; Chern Y; Wang GS
J Neurosci; 2022 Jun; 42(25):5102-5114. PubMed ID: 35606145
[TBL] [Abstract][Full Text] [Related]
5. Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy.
Chen G; Carter RE; Cleary JD; Reid TS; Ranum LP; Swanson MS; Ebner TJ
Neurobiol Dis; 2018 Apr; 112():35-48. PubMed ID: 29331264
[TBL] [Abstract][Full Text] [Related]
6. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
7. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
8. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.
Charizanis K; Lee KY; Batra R; Goodwin M; Zhang C; Yuan Y; Shiue L; Cline M; Scotti MM; Xia G; Kumar A; Ashizawa T; Clark HB; Kimura T; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Gomes-Pereira M; Gourdon G; Sakai N; Nishino S; Foster TC; Ares M; Darnell RB; Swanson MS
Neuron; 2012 Aug; 75(3):437-50. PubMed ID: 22884328
[TBL] [Abstract][Full Text] [Related]
9. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
10. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models.
Cerro-Herreros E; Sabater-Arcis M; Fernandez-Costa JM; Moreno N; Perez-Alonso M; Llamusi B; Artero R
Nat Commun; 2018 Jun; 9(1):2482. PubMed ID: 29946070
[TBL] [Abstract][Full Text] [Related]
11. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function.
Nitschke L; Hu RC; Miller AN; Lucas L; Cooper TA
Nucleic Acids Res; 2023 Feb; 51(3):1245-1259. PubMed ID: 36617982
[TBL] [Abstract][Full Text] [Related]
13. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.
Bargiela A; Sabater-Arcis M; Espinosa-Espinosa J; Zulaica M; Lopez de Munain A; Artero R
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25203-25213. PubMed ID: 31754023
[TBL] [Abstract][Full Text] [Related]
14. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
Michel L; Huguet-Lachon A; Gourdon G
PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
[TBL] [Abstract][Full Text] [Related]
15. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
16. Forebrain glutamatergic neuron-specific Ctcf deletion induces reactive microgliosis and astrogliosis with neuronal loss in adult mouse hippocampus.
Kwak JH; Lee K
BMB Rep; 2021 Jun; 54(6):317-322. PubMed ID: 33612151
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1.
Eltahir MK; Nakamori M; Hattori S; Kimura T; Mochizuki H; Nagano S
PLoS One; 2022; 17(7):e0269683. PubMed ID: 35776705
[TBL] [Abstract][Full Text] [Related]
18. Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.
Nishi M; Kimura T; Igeta M; Furuta M; Suenaga K; Matsumura T; Fujimura H; Jinnai K; Yoshikawa H
PLoS One; 2020; 15(5):e0224912. PubMed ID: 32407311
[TBL] [Abstract][Full Text] [Related]
19. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
[TBL] [Abstract][Full Text] [Related]
20. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
